Glenn Coleman

EVP & Chief Financial Officer · 3 filings · Latest: Sep 30, 2026

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
CRL	Glenn Coleman	EVP & Chief Financial Officer	Sep 30, 2026	Purchase	$297.43	10	$3.0K	27,762	Oct 2 8:27 PM
XRAY	Coleman Glenn	—	Jan 27, 2025	Proposed Sale	$19.75	15,759	$311.2K	—	Jan 27 3:35 PM